Hypothesis

Circadian disruption accelerates the accumulation of senescent cells not merely by lowering NAD+ levels but by dampening BMAL1‑driven transcription of autophagy genes, thereby impairing the removal of damaged macromolecules and fostering a pro‑senescent microenvironment. Restoring circadian amplitude—especially through timed NAD+ precursor administration—will reactivate BMAL1‑dependent autophagic flux and reduce senescent burden independently of direct NAD+-SIRT1 deacetylation.

Mechanistic rationale

• The core clock heterodimer BMAL1/CLOCK drives rhythmic expression of NAMPT, generating NAD+ oscillations that feed back to SIRT1 activity [NAD+-SIRT1 circadian loop].
• SIRT1 deacetylates BMAL1 and PER2 to modulate clock amplitude, creating a bidirectional loop [SIRT1‑clock modulation].
• In aging, declining NAD+ weakens BMAL1 chromatin binding and blunts PER2 rhythms, which correlates with mitochondrial dysfunction [NAD+ decline & clock damping] and increased cellular senescence via NAMPT loss [NAMPT & senescence].
• Crucially, BMAL1 directly regulates transcription of key autophagy regulators (e.g., LC3, ATG5, BECN1) through E‑box motifs in their promoters [BMAL1‑autophagy link]. When BMAL1 activity falls, autophagic flux declines, leading to accumulation of damaged proteins and organelles that trigger the senescence‑associated secretory phenotype (SASP).
• NAD+ supplementation improves NAD+ levels and SIRT1 activity but does not necessarily restore the temporal pattern of BMAL1‑dependent gene expression unless administered in synchrony with the endogenous circadian phase [Timing matters in humans].

Testable predictions

1. In aged mice (24‑month), chronic NAD+ precursor (NMN) given at random times will increase total NAD+ and modestly improve circadian amplitude but will not significantly reduce p16^Ink4a^+ senescent cell numbers.
2. The same NMN dose delivered at circadian Zeitgeber Time 0 (ZT0, onset of the active phase) will produce a larger increase in BMAL1 binding to autophagy gene promoters, enhance LC3‑II conversion, and lower p16^Ink4a^+ and SASP marker (IL‑6, MMP‑3) levels compared with random‑time dosing.
3. Genetic ablation of BMAL1 specifically in hematopoietic or stromal cells will abolish the senolytic effect of timed NMN, even if NAD+ levels are restored, demonstrating that BMAL1‑mediated autophagy is necessary.

Experimental design

• Groups: young (3‑mo) controls, aged mice receiving vehicle, aged mice receiving NMN ad libitum, aged mice receiving NMN only at ZT0, aged mice receiving NMN at ZT12 (opposite phase), and aged mice with BMAL1‑flox crossed to Cre‑ER under a tamoxifen‑inducible promoter for inducible knockout.
• Readouts: (a) liver and spleen NAD+ levels (LC‑MS/MS), (b) circadian gene expression (qPCR of Bmal1, Per2, Nampt) over 24 h, (c) chromatin immunoprecipitation for BMAL1 at autophagy gene promoters, (d) autophagic flux (LC3‑II/I ratio with and without bafilomycin A1, p62 degradation), (e) senescent cell burden (p16^Ink4a^+ immunostaining, SA‑β‑gal activity), (f) SASP cytokines (ELISA), (g) functional assays (grip strength, treadmill endurance).
• Statistical plan: two‑way ANOVA (treatment × time) with post‑hoc Tukey; significance set at p<0.05.

Potential outcomes and interpretation

• If timed NMN markedly boosts BMAL1 promoter occupancy, autophagic flux, and senescent cell clearance while random NMN does not, the hypothesis is supported: circadian gating of BMAL1‑dependent autophagy is a pivotal downstream effector of NAD+ signaling in aging.
• If timed NMN fails to improve autophagy or senescent load despite robust NAD+ rhythms, the hypothesis is refuted, suggesting that circadian influence on senescence operates primarily through other pathways (e.g., NAD+-SIRT1‑mediated DNA repair).
• If BMAL1 knockout negates the benefits of timed NMN, it confirms BMAL1 as the necessary mediator, linking clock integrity directly to proteostatic resilience.

Implications

This work would reposition the circadian system from a mere metabolic modulator to a gatekeeper of cellular quality control, offering a chronotherapeutic strategy to enhance senescent cell removal without relying solely on senolytics. It also underscores the importance of timing NAD+ supplementation to harness the endogenous clock’s repair capacity, potentially improving the efficacy of existing nutraceutical regimens.